TSX closed
Loading markets…

Advertisement

Stocks

Why Bausch Health Companies Inc stock is sliding today

By Wealth Awesome -

This move is archived. Current quotes and coverage live on the stock page.

Stocks & ETFs:BHC.TO

Get BHC alerts:

Photos provided by Pexels

Bausch Health Companies Inc faces a notable decline, with shares dropping over 4% in the latest trading session.

Bausch Health Companies Inc (BHC.TO) experienced a significant downturn, closing at CA$7.16 after a 4.41% drop in value during the last trading day. This decline raises concerns among investors, especially given the company's recent financial reports and market activities.

Advertisement

Bausch Health Companies Inc

BHC.TO

Full stock page →

BHC.TO

Bausch Health Companies Inc

Source:WealthAwesomeWealthAwesome
$1.52 (22.03%)
120 day period
$6.25$7.95$9.65Mar 20Jun 16Sep 10

Market cap

$3.03B

52W high

$11.08

52W low

$6.10

1W change

-9.66%

Beta

0.37

Analyst Price Targets

Based on analyst covering BHC

📉

Wall Street analysts forecast BHC stock price to fall 16.8% over the next 12 months.

Consensus

Bearish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$7.01

-16.8% Upside

Current Price

C$8.42

Last close

Compare analyst targets across the TSX & TSXV →

Analyst ratings and price targets are updated periodically. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on BHC's historical volatility

HistoricalForecast68%95%
C$3.03C$9.10C$15.18C$21.25C$27.33C$33.40TodayMay 4Jul 8Sep 10Oct 23Dec 6Jan 18

30-Day Vol

97.9%

Annualized

90-Day Vol

67.2%

Annualized

Trend (90d)

+50.0%

Annualized drift

90d Mean

C$10.07

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$8.94C$6.38C$12.53
60 trading daysC$9.48C$5.88C$15.29
90 trading daysC$10.07C$5.61C$18.07

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

Investor takeaway: Investors should closely monitor Bausch Health's financial health and market strategies, particularly in light of its substantial net losses and ongoing challenges in the healthcare sector.

Bausch Health's shares down 4.41% in one day

The stock's decline reflects investor concerns over the company's financial health, particularly after reporting a GAAP net loss of CA$1.423 billion in its latest quarter.

Bull case

Despite the recent losses, Bausch Health has reported increased revenues in its recent financial results. This suggests there could be a chance for recovery if the company improves its operational efficiencies and market conditions stabilize.

Bear case

However, the company’s significant net loss, largely due to goodwill impairment charges, raises serious questions about its long-term viability and ability to generate sustainable profits.

Recent Performance Overview

Advertisement

Bausch Health’s stock fell sharply by 4.41% in the last trading session, closing at CA$7.16. This decline follows a troubling financial report that revealed a net loss of CA$1.423 billion, primarily due to a significant goodwill impairment charge. Investors are understandably cautious as they assess the implications of these results for the company's future.

Financial Health Concerns

The recent financial disclosures from Bausch Health highlight ongoing challenges. The company reported a GAAP net loss of CA$1.423 billion, raising concerns about its profitability and sustainability. With a profit margin of -11.47%, the outlook remains uncertain as the company navigates its financial landscape. Investors should pay attention to upcoming earnings reports and management commentary for insights into potential recovery strategies.

Market Response and Future Outlook

The market's reaction to Bausch Health's latest financial results indicates a lack of confidence among investors. The recent participation in healthcare conferences may provide opportunities for management to communicate their strategic vision, but the immediate focus remains on stabilizing the company’s financial performance. Investors are advised to remain vigilant and consider the potential for volatility in the stock as new information emerges.


Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: June 8, 2026
Last Updated: June 8, 2026
PARTNER SPOTLIGHT

Blue Cross Life® Term Life Insurance

Affordable term life coverage in Canada — get a free quote in seconds, no credit card required.

  • Coverage from $100,000 to $5 million, terms of 10–30 years
  • 10% off first-year premiums when couples apply together
  • Fully digital application — many qualify without a medical exam

Sponsored links

Advertisement